IGM Biosciences, Inc. (IGMS) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{
  "main_header": {
    "sid": 1234985,
    "name": "IGM Biosciences, Inc.",
    "stock_name": "IGM Biosciences, Inc.",
    "full_name": "IGM Biosciences, Inc.",
    "name_url": "stocks-analysis/igm-biosciences-inc",
    "exchange": 210,
    "exchangecode": "NAS",
    "country_id": 2,
    "currency": "USD",
    "cmp": "1.27",
    "chg": "0.00",
    "chgp": "0.00%",
    "dir": 0,
    "prev_price": "1.27",
    "mcapval": "43.28",
    "mcap": "Micro Cap",
    "scripcode": "",
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 2305,
    "indexname": "S&P 500",
    "isin": "US4495851085",
    "curr_date": "Aug 15",
    "curr_time": "",
    "bse_nse_vol": "0 ",
    "exc_status": "Active",
    "traded_date": "Aug 15, 2025",
    "traded_date_str": "2025 08 15",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/igm-biosciences-inc-1234985-210&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Is IGM Biosciences, Inc. technically bullish or bearish?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-igm-biosciences-inc-technically-bullish-or-bearish-3547654",
        "imagepath": "",
        "date": "2025-09-20 20:00:05",
        "description": "As of 1 July 2025, the technical trend for IGM Biosciences, Inc. has changed from bearish to mildly bearish. The current stance is mildly bearish, driven by a combination of indicators. The MACD shows a mildly bullish signal on the weekly timeframe but is bearish on the monthly. The moving averages are mildly bearish on the daily timeframe, and both the KST and OBV indicate a mildly bearish stance on the weekly. Dow Theory remains bearish on both weekly and monthly timeframes.\n\nIn terms of performance, IGM Biosciences has significantly underperformed against the S&P 500, with a year-to-date return of -79.21% compared to the S&P 500's 12.22%, and a one-year return of -86.3% versus the S&P 500's 17.14%...."
      },
      {
        "title": "Is IGM Biosciences, Inc. overvalued or undervalued?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-igm-biosciences-inc-overvalued-or-undervalued-3543965",
        "imagepath": "",
        "date": "2025-09-20 18:33:55",
        "description": "As of 30 March 2023, the valuation grade for IGM Biosciences, Inc. moved from does not qualify to risky, indicating a shift in perception regarding its financial health. The company is overvalued based on its current metrics, particularly highlighted by a Price to Book Value of 79.35, an EV to EBIT of 0.38, and an EV to EBITDA of 0.41. In comparison to peers, Lexicon Pharmaceuticals, Inc. has a more favorable EV to EBITDA of -2.8670, while Vanda Pharmaceuticals, Inc. shows an EV to EBITDA of 0.5601, suggesting that IGM may be lagging behind its competitors.\n\nThe stock has significantly underperformed against the S&P 500, with a year-to-date return of -79.21% compared to the index's gain of 12.22%. This stark contrast reinforces the notion that IGM Biosciences, Inc. is not only facing valuation challenges but is also struggling to deliver returns in the current market environment...."
      }
    ],
    "total": 7,
    "sid": "1234985",
    "stock_news_url": "https://www.marketsmojo.com/news/igm-biosciences-inc-1234985"
  },
  "announcements": "",
  "corporate_actions": {
    "msg": "No corporate action Found"
  }
}

News and Views

Is IGM Biosciences, Inc. technically bullish or bearish?

2025-09-20 20:00:05

As of 1 July 2025, the technical trend for IGM Biosciences, Inc. has changed from bearish to mildly bearish. The current stance is mildly bearish, driven by a combination of indicators. The MACD shows a mildly bullish signal on the weekly timeframe but is bearish on the monthly. The moving averages are mildly bearish on the daily timeframe, and both the KST and OBV indicate a mildly bearish stance on the weekly. Dow Theory remains bearish on both weekly and monthly timeframes. In terms of performance, IGM Biosciences has significantly underperformed against the S&P 500, with a year-to-date return of -79.21% compared to the S&P 500's 12.22%, and a one-year return of -86.3% versus the S&P 500's 17.14%....

Is IGM Biosciences, Inc. overvalued or undervalued?

2025-09-20 18:33:55

As of 30 March 2023, the valuation grade for IGM Biosciences, Inc. moved from does not qualify to risky, indicating a shift in perception regarding its financial health. The company is overvalued based on its current metrics, particularly highlighted by a Price to Book Value of 79.35, an EV to EBIT of 0.38, and an EV to EBITDA of 0.41. In comparison to peers, Lexicon Pharmaceuticals, Inc. has a more favorable EV to EBITDA of -2.8670, while Vanda Pharmaceuticals, Inc. shows an EV to EBITDA of 0.5601, suggesting that IGM may be lagging behind its competitors. The stock has significantly underperformed against the S&P 500, with a year-to-date return of -79.21% compared to the index's gain of 12.22%. This stark contrast reinforces the notion that IGM Biosciences, Inc. is not only facing valuation challenges but is also struggling to deliver returns in the current market environment....

View All News